Neuroanatomical basis for the antidepressant-like effects of the 5-HT1A receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test

    loading  Checking for direct PDF access through Ovid

Abstract

In the rat forced swimming test, systemic application of the serotonin 1A (5-HT1A) receptor agonist 8-OH-DPAT reduced immobility (ID50 0.17–1.37 mg/kg, depending on route of application and application schedule). Intracerebroventricular (i.c.v.) or local application into the dorsal raphe nucleus (DRN), a brain area rich in presynaptic 5-HT1A receptors, resulted in a parallel shift of the dose-response curve to the left (ID50 5.1 and 3.9 μg/rat, respectively). Systemic application of the 5-HT1A receptor partial agonist ipsapirone resulted in a U-shaped dose-response curve (maximal effect about 30% immobility reduction at 3–10 mg/kg). Local application of ipsapirone in the DRN reduced immobility (maximal effect 40% at 60 μg/rat). However, 8-OH-DPAT and ipsapirone were still effective after depletion of brain 5-HT by means of 5,7-DHT (150 μg, i.e. v.) or pCPA (either 2 ± 150 mg/kg or ± 350 mg/kg, i.p.) Additionally, in non-lesioned rats: (1) the putative (postsynaptic) 5-HT1A antagonist NAN-190, but not spiperone, haloperidol, prazosin or 1-PP, was able to block the anti-immobility effects of 8-OH-DPAT in a behaviorally specific manner; (2) local application of 8-OH-DPAT and ipsapirone in the lateral septum (a brain area rich in postsynaptic 5-HT1A receptors) reduced immobility (8-OH-DPAT: ID50 11.4 μg/rat; ipsapirone: maximal effect at 30 μg/rat 38%); and (3) pretreatment with ipsapirone resulted in an attenuation of the effect of 8-OH-DPAT when both compounds were administered either systemically or in the lateral septum but not when both compounds were microinjected into the DRN. It is hypothesized that the anti-immobility effects of 5-HT1A receptor agonists are mediated by pre- and postsynaptic 5-HT1A receptors and that they closely reflect the intrinsic activity of these compounds at these receptors.

Related Topics

    loading  Loading Related Articles